Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Y Ku

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2018
Positron-Emission Tomography Scan-Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography NonrespondersMegan Greally, Joanne F Chou, Daniela Molena, et al.
Annals of Surgical Oncology|December 28, 2013
Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancersDo Joong Park, Changhwan Yoon, Nicholas Thomas, et al.
Journal of Geriatric Oncology|August 16, 2021
A nutritional management algorithm in older patients with locally advanced esophageal cancerRyan H Moy, Shalom Sabwa, Steven B Maron, et al.
Annals of Surgery|November 20, 2020
Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?Smita Sihag, Tamar Nobel, Meier Hsu, et al.
Future Oncology (London, England)|May 26, 2022
PD-L1 expression and overall survival in Asian and western patients with gastric cancerSun Young Rha, Geoffrey Y Ku, Hyo Song Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 4, 2024
Patient metabolic profile defined by liver and muscle <sup>18</sup>F-FDG PET avidity is independently associated with overall survival in gastric cancerGerardo A Vitiello, Vetri Sudar Jayaprakasam, Laura H Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2026
NRG-GI007: Phase I study of OBP-301, an oncolytic virus, and definitive chemoradiation in locally advanced esophageal cancerGeoffrey Y Ku, Kathryn Winter, David Ilson, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 18, 2018
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinomaArianna Barbetta, Meier Hsu, Kay See Tan, et al.
Cancer Immunity|June 6, 2009
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanomaJianda Yuan, Geoffrey Y Ku, Humilidad F Gallardo, et al.
The British Journal of Surgery|December 16, 2025
Genomic and clinical parallels between US and Japanese gastric cancers: a propensity score-matched cohort studyMasaya Nakauchi, Colin Court, Henry S Walch, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2018
Positron-Emission Tomography Scan-Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography NonrespondersMegan Greally, Joanne F Chou, Daniela Molena, et al.
Annals of Surgical Oncology|December 28, 2013
Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancersDo Joong Park, Changhwan Yoon, Nicholas Thomas, et al.
Journal of Geriatric Oncology|August 16, 2021
A nutritional management algorithm in older patients with locally advanced esophageal cancerRyan H Moy, Shalom Sabwa, Steven B Maron, et al.
Annals of Surgery|November 20, 2020
Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?Smita Sihag, Tamar Nobel, Meier Hsu, et al.
Future Oncology (London, England)|May 26, 2022
PD-L1 expression and overall survival in Asian and western patients with gastric cancerSun Young Rha, Geoffrey Y Ku, Hyo Song Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 4, 2024
Patient metabolic profile defined by liver and muscle <sup>18</sup>F-FDG PET avidity is independently associated with overall survival in gastric cancerGerardo A Vitiello, Vetri Sudar Jayaprakasam, Laura H Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2026
NRG-GI007: Phase I study of OBP-301, an oncolytic virus, and definitive chemoradiation in locally advanced esophageal cancerGeoffrey Y Ku, Kathryn Winter, David Ilson, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 18, 2018
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinomaArianna Barbetta, Meier Hsu, Kay See Tan, et al.
Cancer Immunity|June 6, 2009
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanomaJianda Yuan, Geoffrey Y Ku, Humilidad F Gallardo, et al.
The British Journal of Surgery|December 16, 2025
Genomic and clinical parallels between US and Japanese gastric cancers: a propensity score-matched cohort studyMasaya Nakauchi, Colin Court, Henry S Walch, et al.
Pageof 11